Home›Companies›Biotech & Pharma›Stork Therapeutics

Stork Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing May 8, 2025·Suggest an edit

About Stork Therapeutics

Stork Therapeutics is a private company based in San Francisco, California, incorporated in 2024 in Delaware. It has reported $1,345,000 raised in one offering on Form D since May 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 24, 2025May 8, 2025$1,345,000of $2.7M target3$448KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Stork Therapeutics's Form D filed May 8, 2025.

BK
GF
Gregg Fine
Executive officer, director and promoter

Sources

  1. SECStork Therapeutics, Inc. filing history